Commentary|Videos|June 19, 2026

A Roadmap to Dispenser DSCSA Readiness

Justin Macy, PharmD, JD, and Andrew Funk, PharmD, of NABP, emphasize that compliance is a critical safeguard against the rising threat of counterfeit and illegitimate products.

As the final implementation milestone for the Drug Supply Chain Security Act (DSCSA) approaches this November, small dispensers—those with fewer than 25 full-time employees—must finalize their transition into a fully interoperable digital supply chain.